Chinese General Practice ›› 2021, Vol. 24 ›› Issue (18): 2285-2290.DOI: 10.12114/j.issn.1007-9572.2021.00.481

• Monographic Research • Previous Articles     Next Articles

Association of Thyroid Autoantibody and Anti-glutamic Acid Decarboxylase Antibody in Physical Examinees 

  

  1. 1.Health Science Department,Peking Union Medical College Hospital,Beijing 100730,China
    2.Rheumatology and Immunology Department,Peking Union Medical College Hospital,Beijing 100730,China
    *Corresponding author:XU Tengda,Associate chief physician;E-mail:xutd@pumch.cn
  • Published:2021-06-20 Online:2021-06-20

体检人群甲状腺自身抗体与抗谷氨酸脱羧酶抗体的相关性研究

  

  1. 1.100730北京市,北京协和医院健康医学部 2.100730北京市,北京协和医院风湿免疫科
    *通信作者:徐腾达,副主任医师;E-mail:xutd@pumch.cn

Abstract: Background Autoimmune thyroid disease and autoimmune diabetes often exist simultaneously.The frequency of thyroid autoantibody(TA) is higher in autoimmune diabetes patients.Objective To investigate the association of anti-glutamic acid decarboxylase autoantibody(anti-GADA) and TA in Chinese physical examinees.Methods The PUMCH Health Management database was searched for physical examinees who had their anti-GADA and TA tested from 2012 to 2015.The results of anti-GADA,thyroid stimulating hormone(TSH),thyroid peroxidase antibody(TPOAb) and thyroglobulin antibody(TgAb)and other data were collected.TA positive was defined as TPOAb positive or TgAb positive.Prevalence of anti-GADA was compared between TA positive and TA negative subjects,and also between diabetic and nondiabetic subjects.Clinical characteristics were compared among subjects with anti-GADA negative,anti-GADA low titer and anti-GADA high titer.Risk factors of TA positivity,TPOAb positivity and TgAb positivity were analyzed by multivariate Logistic regression.Results There were 36 048 eligible participants totally,among whom 5 000 (13.9%) were TA positive〔3 321(9.2%) were TPOAb positive;3 552(9.9%) were TgAb positive〕 and 31 048(86.1%) were TA negative;2 600 (7.2%) met the diagnostic criteria of diabetes and 33 448 (92.8%) did not;185 (0.5%) were anti-GADA positive and 35 863 (99.5%) were anti-GADA negative.The prevalence of anti-GADA in TA positive subjects (n=51,1.0%) was significantly higher than that in TA negative subjects (n=134,0.4%)(χ2=29.203,P<0.001).The prevalence of TA positivity was lower in diabetic subjects(n=280,10.8%)than that in nondiabetic ones (n=4 720,14.1%)(χ2=22.558,P<0.001).The prevalence of anti-GADA is higher in diabetic subjects(n=31,1.2%)than that in nondiabetic ones (n=154,0.5%)(χ2=25.310,P<0.001).The frequency of TA raised from anti-GADA negative group to anti-GADA low titer group to anti-GADA high titer group (13.8%,23.7%,39.1%,respectively,P<0.05).In the multivariate Logistic regression,age〔OR=1.015,95%CI(1.012,1.018)〕,sex〔female:OR=3.483,95%CI(3.259,3.723)〕,diabetes〔yes:OR=0.837,95%CI(0.731,0.958)〕,anti-GADA〔low titer:OR=1.900,95%CI(1.266,2.853);high titer:OR=4.259,95%CI(2.260,8.025)〕were risk factors for presence of TA(P<0.05).Conclusion Anti-GADA has a low prevalence in Chinese adult physical examinees.The presence of TA is associated with GADA positivity.

Key words: Diabetes mellitus, Thyroid diseases, Glutamic acid decarboxylase autoantibody, Thyroid autoantibody, Root cause analysis

摘要: 背景 自身免疫性甲状腺疾病和自身免疫性糖尿病常同时存在,而自身免疫性糖尿病患者继发甲状腺抗体(TA)阳性的风险升高。目的 研究我国体检人群中TA与抗谷氨酸脱羧酶抗体(GADA)的关系。方法 检索北京协和医院健康管理数据库,查询2012—2015年在北京协和医院进行健康体检并检测GADA和TA的人群,收集其体检资料和GADA、促甲状腺激素、甲状腺球蛋白抗体(TgAb)、甲状腺过氧化物酶抗体(TPOAb)水平,其中TPOAb、TgAb任一阳性记为TA阳性。比较TA阳性与阴性人群GADA阳性率,糖尿病与非糖尿病人群TA、GADA阳性率;分析GADA阴性、低滴度、高滴度人群的一般资料,探究体检人群TA阳性、TPOAb阳性、TgAb阳性的影响因素。结果 共36 048例体检人群符合纳入标准,其中TA阳性5 000例(13.9%)〔TPOAb阳性3 321例(9.2%)、TgAb阳性3 552例(9.9%)〕,TA阴性31 048例(86.1%);符合糖尿病诊断2 600例(7.2%),不符合33 448例(92.8%);GADA阳性185例(0.5%),GADA阴性35 863例(99.5%)。TA阳性人群中GADA阳性率〔51例(1.0%)〕高于TA阴性人群〔134例(0.4%)〕(χ2=29.203,P<0.001)。糖尿病人群中TA阳性率〔280例(10.8%)〕低于非糖尿病人群〔4 720例(14.1%)〕,GADA阳性率〔31例(1.2%)〕高于非糖尿病人群〔154例(0.5%)〕(χ2值分别为22.558、25.310,P<0.001)。GADA阴性、低滴度、高滴度体检人群中TA阳性率逐步递增(分别是13.8%、23.7%、39.1%)(P<0.05)。多因素Logistic回归分析结果显示:年龄〔OR=1.015,95%CI(1.012,1.018)〕、性别〔女:OR=3.483,95%CI(3.259,3.723)〕、糖尿病〔是:OR=0.837,95%CI(0.731,0.958)〕、GADA〔低滴度:OR=1.900,95%CI(1.266,2.853);高滴度:OR=4.259,95%CI(2.260,8.025)〕是体检人群TA阳性的影响因素(P<0.05)。结论 我国体检人群中GADA阳性率较低,GADA阳性与TA阳性存在相关性。

关键词: 糖尿病, 甲状腺疾病, 抗谷氨酸脱羧酶抗体, 甲状腺自身抗体, 影响因素分析